1.53BMarket Cap-3.83P/E (TTM)
18.300High17.530Low462.41KVolume17.870Open17.910Pre Close8.20MTurnover0.63%Turnover RatioLossP/E (Static)87.03MShares20.33052wk High-50.14P/B1.30BFloat Cap5.12052wk Low--Dividend TTM73.88MShs Float37.040Historical High--Div YieldTTM4.30%Amplitude0.000Historical Low17.725Avg Price1Lot Size
Travere Therapeutic Stock Forum
Travere Therapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.02%)
Someone buying large blocks 150k, 50k....
Does anybody know what's going on?
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). The voluntary enrollment pause enables the Company to work to address ...
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...
🤔 no action even for AH.
No comment yet